A clinical trial funded by AstraZeneca evaluated the use of short-acting GLP-1 receptor agonists as an add-on treatment to insulin therapy in type 1 diabetes.
Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.
The updated labeling recommends temporary discontinuation of SGLT2 inhibitors before scheduled surgery.
Creating a place where patients seek diabetes care and counseling.
The CDC’s 2020 National Diabetes Statistics Report outlines the current state of the disease.
Patient access to portal self-management tools through mobile devices may help significantly improve diabetes care.
The FreeStyle Libre system decreased HbA1c, increased time in glucose range, and reduced diabetes complications.
The pharmacist’s role in diabetes management is more important than ever before, given the number of patients with diabetes and the number of options available for treating them.
Novo Nordisk has fired the first “shot heard around the health care world.”
Rosiglitazone, which is used to treat type 2 diabetes, may increase the risk of heart problems.